CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-05 | Rosenbaum David P. Chief Development Officer | Grant or award | +8,500 | 30,162 | ||
| 2021-01-05 | Rosenbaum David P. Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +146,755 | 146,755 | ||
| 2021-01-05 | Rosenbaum David P. Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2021-01-05 | Renz Justin A Chief Financial Officer | Grant or award | +32,612 | 41,898 | ||
| 2021-01-05 | Renz Justin A Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +146,755 | 146,755 | ||
| 2021-01-05 | RAAB MICHAEL President & CEO | Grant or award | +115,102 | 219,822 | ||
| 2021-01-05 | RAAB MICHAEL President & CEO | Grant or award · Stock Option (Right to Buy) | +517,959 | 517,959 | ||
| 2021-01-05 | Jacobs Jeffrey W Chief Scientific Officer | Grant or award | +32,612 | 125,474 | ||
| 2021-01-05 | Jacobs Jeffrey W Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +146,755 | 146,755 | ||
| 2021-01-05 | Blanks Robert | Grant or award | +32,612 | 113,322 | ||
| 2021-01-05 | Blanks Robert | Grant or award · Stock Option (Right to Buy) | +146,755 | 146,755 | ||
| 2021-01-05 | Rodriguez Susan Chief Commercial Officer | Grant or award | +32,612 | 46,525 | ||
| 2021-01-05 | Rodriguez Susan Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +146,755 | 146,755 | ||
| 2021-01-05 | GRAMMER ELIZABETH A | Grant or award | +32,612 | 103,924 | ||
| 2021-01-05 | GRAMMER ELIZABETH A | Grant or award · Stock Option (Right to Buy) | +146,755 | 146,755 | ||
| 2020-12-21 | Jacobs Jeffrey W Chief Scientific Officer | Sale | −3,949 | $6.88 | $27K | 92,862 |
| 2020-12-15 | GRAMMER ELIZABETH A | Gift | −405 | 72,122 | ||
| 2020-12-15 | GRAMMER ELIZABETH A | Gift | −405 | 71,717 | ||
| 2020-12-15 | GRAMMER ELIZABETH A | Gift | −405 | 71,312 | ||
| 2020-12-15 | GRAMMER ELIZABETH A | Gift | +405 | 2,971 |
Page 32 of 38 · 756 trades